What assessments should a nurse complete before administering hydrochlorothiazide, including checks for hyperkalemia, hyponatremia, hypoglycemia, sulfonamide or penicillin allergy, osteoporosis risk, hypouricemia, renal function, and blood pressure?

Pre-Administration Nursing Assessment for Hydrochlorothiazide

Before administering hydrochlorothiazide, the nurse must verify sulfonamide allergy status (not penicillin), check baseline electrolytes focusing on sodium and potassium levels, assess renal function, measure blood pressure, and review for risk factors predisposing to hyponatremia including advanced age, low body weight, and female sex. 1, 2

Critical Allergy Assessment

• Check for sulfonamide (sulfa) allergy, as hydrochlorothiazide is a sulfonamide-containing drug and can cause severe hypersensitivity reactions including anaphylaxis-like presentations that may mimic septic shock 2
• Penicillin allergy is not relevant to hydrochlorothiazide administration—there is no cross-reactivity between penicillin and sulfonamide diuretics 2
• Document any history of allergic reactions to other sulfonamide medications 2

Electrolyte Monitoring Requirements

Hyponatremia Risk (Primary Concern)

• Assess serum sodium level before administration, as thiazide-induced hyponatremia is common and potentially life-threatening 1, 3, 4
• Identify high-risk patients: elderly (each 10-year age increment doubles risk), low body weight (each 5 kg decrease increases risk by 30%), and female sex 3, 4
• Monitor for warning signs: dryness of mouth, thirst, weakness, lethargy, drowsiness, restlessness, muscle pains or cramps, and gastrointestinal disturbances 1
• Hyponatremia can develop early after initiation or after months to years of therapy 4

Hypokalemia Risk (Not Hyperkalemia)

• Check serum potassium level, as hypokalemia—not hyperkalemia—is the primary electrolyte concern with hydrochlorothiazide monotherapy 1, 5
• Hypokalemia occurs in approximately 12.6% of hydrochlorothiazide users, affecting roughly 2 million U.S. adults 5
• Higher risk groups include women (2.2-fold increased risk), non-Hispanic Blacks (1.65-fold increased risk), underweight patients (4.3-fold increased risk), and those on therapy ≥5 years (1.47-fold increased risk) 5
• Note: Hyperkalemia may occur only when hydrochlorothiazide is combined with angiotensin receptor blockers or ACE inhibitors, not with hydrochlorothiazide alone 6

Renal Function Assessment

• Evaluate estimated glomerular filtration rate (eGFR) and serum creatinine, as thiazides become less effective in moderate-to-severe renal impairment 7, 8
• Thiazides are useful only in mild renal insufficiency; loop diuretics become necessary as renal function deteriorates 7
• Low doses should be used to prevent hypovolemia, hyponatremia, and hypokalemia that may worsen renal blood flow 7

Baseline Blood Pressure

• Measure blood pressure to establish baseline for monitoring therapeutic response and to assess for orthostatic hypotension risk 1
• Patients may experience potentiation of orthostatic hypotension, especially when combined with alcohol, barbiturates, or narcotics 1

Additional Assessments

Metabolic Considerations

• Review blood glucose levels in diabetic patients, as hydrochlorothiazide may require adjustment of antidiabetic drug dosages 1
• Assess for hyperuricemia or gout history, as thiazides may precipitate acute gout in susceptible patients 1

Hepatic Function

• Evaluate liver function in patients with hepatic impairment, as thiazides can precipitate hepatic coma in severe liver disease 1

Drug Interactions

• Review medication list for lithium (diuretics reduce lithium clearance and greatly increase toxicity risk), corticosteroids or ACTH (intensify hypokalemia), digitalis (hypokalemia potentiates cardiac arrhythmias), and cholestyramine/colestipol (reduce hydrochlorothiazide absorption by up to 85%) 1

Items NOT Requiring Assessment

• Hypouricemia: Hydrochlorothiazide causes hyperuricemia, not hypouricemia 1
• Osteoporosis risk: Not a primary concern, though thiazides decrease calcium excretion 1
• Penicillin allergy: No cross-reactivity with hydrochlorothiazide 2
• Hyperkalemia: Only relevant when combined with renin-angiotensin system blockers, not with hydrochlorothiazide monotherapy 5, 6